Pharmaron

Leading global CRO/CDMO founded in 2004, with 19,000+ employees and operations in China, UK and US. UK facilities include Liverpool (cGMP manufacturing of protein therapeutics, viral vectors and vaccines, with £151M expansion for gene therapy) and Cramlington (commercial API synthesis). FDA, EMA, MHRA, NMPA, PMDA and Health Canada approved.